bioAffinity Technologies, Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

bioAffinity Technologies, Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. 1 Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar Interventional pulmonologist, medical oncologist and thoracic surgeon will discuss how CyPath ® Lung results have made a critical difference in their practices CyPath…